PRS2 A COST-MINIMIZATION ANALYSIS COMPARING MOXIFLOXACIN VERSUS LEVOFLOXACIN AND CEFTRIAXONE FOR THE TREATMENT OF PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA: RESULTS FROM THE MOTIVTRIAL
- Publication date
- Publisher
- 'Elsevier BV'
- Doi
- DOI:10.1016/S1098-3015(10)65112-1